Rita C. Bezerra

Sao Paulo, SP, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Correction: Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection.

Correction: Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection.

Journal: PLoS neglected tropical diseases

Published: November 13, 2025

Quantitative PCR for parasitemia monitoring and preemptive therapy in patients with Chagas disease and autoimmune rheumatic disorders undergoing biologic treatment: a case series.

Quantitative PCR for parasitemia monitoring and preemptive therapy in patients with Chagas disease and autoimmune rheumatic disorders undergoing biologic treatment: a case series.

Journal: Revista da Sociedade Brasileira de Medicina Tropical

Published: November 30, 2024

Multiple myeloma and Chagas disease: qPCR as a marker for preemptive antiparasitic therapy: a case reports series and review.

Multiple myeloma and Chagas disease: qPCR as a marker for preemptive antiparasitic therapy: a case reports series and review.

Journal: Revista do Instituto de Medicina Tropical de Sao Paulo

Published: October 03, 2023

Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection.

Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection.

Journal: PLoS neglected tropical diseases

Published: August 16, 2023

Assessment of biomarkers and clinical parameters as predictors of survival in patients with chagasic heart failure.

Assessment of biomarkers and clinical parameters as predictors of survival in patients with chagasic heart failure.

Journal: PLoS neglected tropical diseases

Published: July 28, 2023

Aplastic Anemia and Chagas Disease: T. cruzi Parasitemia Monitoring by Quantitative PCR and Preemptive Antiparasitic Therapy.

Aplastic Anemia and Chagas Disease: T. cruzi Parasitemia Monitoring by Quantitative PCR and Preemptive Antiparasitic Therapy.

Journal: Tropical medicine and infectious disease

Published: August 10, 2022

Role of T. cruzi exposure in the pattern of T cell cytokines among chronically infected HIV and Chagas disease patients.

Role of T. cruzi exposure in the pattern of T cell cytokines among chronically infected HIV and Chagas disease patients.

Journal: Clinics (Sao Paulo, Brazil)

Published: March 06, 2017

CHAGASIC MENINGOENCEPHALITIS IN AN HIV INFECTED PATIENT WITH MODERATE IMMUNOSUPPRESSION: PROLONGED SURVIVAL AND CHALLENGES IN THE HAART ERA.

CHAGASIC MENINGOENCEPHALITIS IN AN HIV INFECTED PATIENT WITH MODERATE IMMUNOSUPPRESSION: PROLONGED SURVIVAL AND CHALLENGES IN THE HAART ERA.

Journal: Revista do Instituto de Medicina Tropical de Sao Paulo

Published: March 14, 2015

Evaluation of the "Symbiosys" immunoassay for the serological diagnosis of Chagas disease.

Evaluation of the "Symbiosys" immunoassay for the serological diagnosis of Chagas disease.

Journal: Revista do Instituto de Medicina Tropical de Sao Paulo

Published: April 14, 2012

Showing 1-9 of 9

Last Updated: 09/26/2026